Cannakeys

Unlocking the Science of Cannabis

CK Home / Cannabidivarin (CBDV) Cannabinoid Research

Cannabidivarin (CBDV) Cannabinoid Research

Cannabidivarin (CBDV) Research Dashboard

19

Primary Studies

18

Related Studies

37

Total Studies

Clinical Studies

1

Clinical Meta-analyses

4

Double-blind human trials

1

Clinical human trials

Pre-Clinical Studies

3

Meta-analyses/Reviews

3

Animal studies

7

Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 37 studies associated with Cannabidivarin (CBDV).

Here is a small sampling of Cannabidivarin (CBDV) studies by title:

  • Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial
  • Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts
  • In Silico Binding Analysis of Cannabinoids with Eph Receptors for Therapeutic Use in Gliomas
  • Inhibitory Effects of Cannabinoids on Acetylcholinesterase and Butyrylcholinesterase Enzyme Activities
  • Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

Components of the Cannabidivarin (CBDV) Research Dashboard

  • Top medical conditions associated with Cannabidivarin (CBDV)
  • Proven effects in clinical trials for Cannabidivarin (CBDV)
  • Receptors associated with Cannabidivarin (CBDV)
  • Individual study details for Cannabidivarin (CBDV)

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Cannabidivarin (CBDV)

Description of Cannabidivarin (CBDV)

CBDV belongs to the CBD family of phytocannabinoids and it shares several characteristics such as being non-psychoactive (i.e., there are no cognitive changes associated with it). CBDV occurs naturally in cannabis and has been gaining attention in the research community for its therapeutic potential relevant to numerous chronic patient populations such as those challenged by epilepsy, inflammation, autism, and chronic pains for example. Typically higher contents of CBDV are found in strains abundant in CBD.

Other Names:

Cannabidivarin

Cannabidivarol, CBDV, CBD-V and other supplier-based synonyms.


IUPAC Name: 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol


Molecular Formula: C19H26O2


Source–PubChem

Cannabidivarin (CBDV) Properties and Effects

CBDV may:


Cannabidivarin (CBDV) Receptor Binding

Endocannabinoid System (ECS) and CBDV:



Endocannabinoidome (eCBome) and CBDV:




Ki legend:



  • Full/strong agonist Ki ~1-9nM

  • Moderate agonist Ki ~10-99nM

  • Weak agonist Ki ~100-999nM

  • Very weak agonist Ki ~1,000-up nM


(the reader is reminded that a smaller Ki is associated with the strongest effects)

Top  

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.